Ctexli offers hope for patients with a previously untreated metabolic disorder, Cerebrotendinous Xanthomatosis. The U.S. Food and Drug Administration (FDA) has approved Ctexli (chenodiol) as the first treatment…
Read MoreDrug Evaluation and Research
FDA Approves Medication for Obstructive Sleep Apnea
First OSA drug treatment for obese adults offers new hope alongside diet and exercise. The FDA recently approved Zepbound (tirzepatide) as the first drug treatment for moderate to…
Read More
FDA Moves to Eliminate Oral Phenylephrine from OTC Nasal Decongestants
Review finds oral phenylephrine ineffective, leading to a proposal for market removal. The U.S. Food and Drug Administration (FDA) recently proposed removing oral phenylephrine from over-the-counter (OTC) products…
Read More
FDA Approves New Hemophilia Treatment Hympavzi
Novel therapy targets blood-clotting proteins to prevent bleeding episodes. The U.S. Food and Drug Administration (FDA) has approved Hympavzi (marstacimab) as a novel treatment for hemophilia. The drug…
Read MoreFDA Approves New Schizophrenia Treatment with a Breakthrough Mechanism
Cobenfy offers an alternative that addresses symptoms of schizophrenia with a different approach. The U.S. Food and Drug Administration (FDA) recently approved Cobenfy (xanomeline and trospium chloride) for…
Read More
FDA Approves First Epinephrine Nasal Spray Treatment for Anaphylaxis
“Neffy” offers a needle-free option for rapid emergency treatment of severe allergic reactions. The U.S. Food and Drug Administration (FDA) has approved Neffy, the first epinephrine nasal spray…
Read More
FDA Approves Treatment for Uncomplicated UTIs
The medication, Pivya, is now an option for women with uncomplicated urinary tract infections. The Food and Drug Administration (FDA) approved Pivya tablets for treating uncomplicated urinary tract…
Read More